Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-25T07:19:21.544Z Has data issue: false hasContentIssue false
  • English
  • Français

Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children

Published online by Cambridge University Press:  15 May 2009

K. M. Lucas ,
R. C. Sanders ,
A. Rongap ,
T. Rongap ,
S. Pinai  and
M. P. Alpers
K. M. Lucas
Affiliation:
Department of Microbiology, La Trobe University, Bundoora, Australia Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea
R. C. Sanders*
Affiliation:
Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea
A. Rongap
Affiliation:
Goroka Base Hospital, Goroka, Papua New Guinea
T. Rongap
Affiliation:
Goroka Base Hospital, Goroka, Papua New Guinea
S. Pinai
Affiliation:
University of Papua New Guinea, Faculty of Medicine, Port Moresby, Papua New Guinea
M. P. Alpers
Affiliation:
Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea
*
*R. C. Sanders, PNG Institute of Medical Research, P.O. Box 60, Goroka E.H.P., Papua New Guinea.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Eighty-seven cases of subacute sclerosing panencephalitis (SSPE) were diagnosed from September 1988 to April 1991 in Papua New Guinea (PNG), by demonstration of high-titre measles-specific antibodies in cerebrospinal fluid (CSF). For 1990 the annual incidence of SSPE, for the study provinces, was calculated to be 56 cases per million under 20 years of age and it is expected that this figure will be higher in 1991. The mean age of presentation was 4.9 years, with a male to female ratio of 1.8:1. An elevation in the ratio of immunoglobulin G as a percentage of total protein in CSF and an increase in the CSF:serum immunoglobulin G ratio was shown in SSPE patients. The dramatic appearance and high frequency of the disease in PNG might relate to the early age of measles infection encountered in children in this country.

Type
Research Article
Information
Epidemiology & Infection , Volume 108 , Issue 3 , June 1992 , pp. 547 - 553
Copyright
Copyright © Cambridge University Press 1992

References

REFERENCES

1.Jabbour, JT, Duenas, DA, Sever, JL, Krebs, HM, Horta-Barbosa, L. Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE Registry. JAMA 1972; 220: 959–62.CrossRefGoogle ScholarPubMed
2.Robbins, SJ, Fiumara, F, Appleton, B, Burke, C. Subacute sclerosing panencephalitis (SSPE): a report of 16 cases. Aust NZ J Med 1984; 14: 126–30.CrossRefGoogle Scholar
3.Soffer, D, Rannon, L, Alter, M, Kahana, E, Feldman, S. Subacute sclerosing panencephalitis: an epidemiologic study in Israel. Am J Epidemiol 1976; 103: 67–74.CrossRefGoogle ScholarPubMed
4.Risk, WS, Haddad, FS. The variable natural history of subacute sclerosing panencephalitis. A study of 118 cases from the Middle East. Arch Neurol 1979; 36: 610–14.CrossRefGoogle ScholarPubMed
5.Sanders, RC, Brian, M, Rongap, A, Watt, D, Alpers, MP. High incidence of subacute sclerosing panencephalitis (SSPE) in young children in Papua New Guinea. Med J Aust 1990; 153: 740.CrossRefGoogle ScholarPubMed
6.Jabbour, JT, Garcia, JH, Lemmi, H, Raglan, J, Duenas, DA, Sever, JL. Subacute sclerosing panencephalitis. A multidisciplinary study of eight cases. JAMA 1969; 207: 2248–54.CrossRefGoogle ScholarPubMed
7.Dyken, PR, Swift, A, DuRant, RH. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Ann Neurol 1982; 11: 359–64.CrossRefGoogle ScholarPubMed
8.Cremer, NE, Cossen, CK, Shell, G, Diggs, J, Gallo, D, Schmidt, NJ. Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses. J Clin Microbiol 1985; 21: 869–74.CrossRefGoogle ScholarPubMed
9.Rogers, S, Sanders, RC, Alpers, MP. Immunogenicity of standard dose Edmonston–Zagreb measles vaccine in highland Papua New Guinean children from four months of age. J Trop Med Hyg 1991; 94: 88–91.Google ScholarPubMed
10.Bradford, MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54.CrossRefGoogle ScholarPubMed
11.Musher, DM, Luchi, MJ, Watson, DA, Hamilton, R, Baughn, RE. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis 1990; 161: 728–35.Google ScholarPubMed
12.Papua New Guinea National Statistical Office. 1990 National Population Census Preliminary Figures. Port Moresby: National Statistical Office, April 1991.Google Scholar
13.Nerenberg, ST, Prasad, R, Rothman, ME. Cerebrospinal fluid IgG, IgA, IgM, IgD and IgE levels in central nervous system disorders. Neurology 1978; 28: 988–90.CrossRefGoogle ScholarPubMed
14.Mingioli, ES, Strober, W, Tourtellotte, WW, Whitaker, JN, McFarlin, DD. Quantitation of IgG, IgA and IgM in the CSF by radioimmunoassay. Neurology 1978; 28: 991–5.CrossRefGoogle ScholarPubMed
15.Modlin, JF, Halsey, NA, Eddins, DL et al. , Epidemiology of subacute sclerosing panencephalitis. J Pediatr 1979; 94: 231–6.CrossRefGoogle ScholarPubMed
16.Saha, V, Jacob John, T, Mukundan, P et al. , High incidence of subacute sclerosing panencephalitis in South India. Epidemiol Infect 1990; 104: 151–6.CrossRefGoogle ScholarPubMed
17.Sever, JL. Persistent measles infection of the central nervous system: subacute sclerosing panencephalitis. Rev Infect Dis 1983; 5: 467–73.CrossRefGoogle ScholarPubMed
18.Cuttler, Rwp, Merler, E, Hammerstad, JP. Production of antibody by the central nervous system in subacute sclerosing panencephalitis. Neurology 1968; 18: 129–32.CrossRefGoogle Scholar
19.Witt, CS, Alpers, MP. Impaired cell-mediated immunity in Papua New Guinean infants. PNG Med J 1991; 34: 90–7.Google ScholarPubMed
20.Coakley, KJ, Coakley, CA, Smith, TA. Measles admissions and deaths in the paediatric ward of Goroka Base Hospital. Report to the Department of Health. Papua New Guinea Institute of Medical Research, Goroka 1990.Google Scholar
21.Halsey, NA, Modlin, JF, Jabbour, JT, Dubey, L, Eddins, DL, Ludwig, DD. Risk factors in subacute sclerosing panencephalitis: a case control study. Am J Epidemiol 1980; 111: 415–24.CrossRefGoogle ScholarPubMed
22.Rittner, C, Meier, EMM, Stradman, B et al. , Partial C4 deficiency in subacute sclerosing panencephalitis. Immunogenetics 1984; 20: 407–15.CrossRefGoogle ScholarPubMed
23.Zilber, N, Rannon, L, Alter, M, Kahana, E. Measles, measles vaccination and risk of subacute sclerosing panencephalitis (SSPE). Neurology 1983; 33: 1558–64.Google ScholarPubMed
24.Papua New Guinea Department of Health. National Health Plan 1991–1995. Port Moresby: Department of Health, 1991: 228.Google Scholar